Cancer Family
Neoplasm
CI-CAN-00000001Explore in graph →
Non-malignant22,971 active trials259 approved drugs4,031 evidence items
Loading cancer entity…
Cancer Family
CI-CAN-00000001Explore in graph →
Clinical trials
105,884 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05371392 | Polymorphism of ITGA4 Gene in Chronic Lymphocytic Leukemia | unknown | — | 80 | Sohag UniversityOTHER | 1 | Jun 20, 2024 | clinicaltrials |
| NCT06018935 | A Cohort Establishment Study of Total Management of Ovarian Cancer | unknown | — | 500 | Sichuan Cancer Hospital and Research InstituteOTHER | 1 | Jun 20, 2024 | clinicaltrials |
| NCT06427993 | Urine DNA Methylation Detection for Hematuria Evaluation | unknown | — | 71 | Changhai HospitalOTHER | 1 | Jun 20, 2024 | clinicaltrials |
| NCT06465771 | Feasibility of a Youth-led NCD Risk Reduction Initiative in Selected Schools of Slums in Karachi, Pakistan: a Mixed-methods, pre-and Post-intervention Study | unknown | N/A | 40 | Aga Khan UniversityOTHER | 0 | Jun 20, 2024 | clinicaltrials |
| NCT06466265 | Study of DNP002 in Patients With Solid Tumors | unknown | Phase 1 | 36 | Kumho HT Inc.INDUSTRY | 1 | Jun 20, 2024 | clinicaltrials |
| NCT05155618 | Intervention Study in Prostate Cancer Patients Undergoing Radiotherapy(MicroStyle) | unknown | N/A | 311 | European Institute of OncologyOTHER | 1 | Jun 18, 2024 | clinicaltrials |
| NCT06203574 | Clinical Study of TROP-2 PET/CT for Noninvasive Diagnosis of Solid Tumors | unknown | N/A | 60 | Huashan HospitalOTHER | 1 | Jun 18, 2024 | clinicaltrials |
| NCT06409416 | Tumor Cell Plasticity and Aggressiveness in Human Non-small Cell Lung Cancer | unknown | — | 20 | Casa Sollievo della Sofferenza IRCCSOTHER | 0 | Jun 18, 2024 | clinicaltrials |
| NCT06464614 | Adebrelimab in Combination With Apatinib and Chemotherapy/Chemoradiotherapy in Immuno-experienced Second-line ESCC. | unknown | Phase 2 | 54 | The First Affiliated Hospital of Henan University of Science and TechnologyOTHER | 1 | Jun 18, 2024 | clinicaltrials |
| NCT05422027 | Selinexor Plus VRd in High Risk Newly Diagnosed Multiple Myeloma | unknown | Phase 1 / Phase 2 | 42 | Xia ZhongjunOTHER | 1 | Jun 17, 2024 | clinicaltrials |
| NCT05422066 | Selinexor Plus R-CHOP in High-risk GCB-subtype Diffuse Large B-Cell Lymphoma | unknown | Phase 2 | 50 | Li ZhimingOTHER | 1 | Jun 17, 2024 | clinicaltrials |
| NCT05816499 | Cadonilimab in Patients (Pts) With Advanced Non-small Cell Lung Cancer (NSCLC)(AK104IIT018) | unknown | Phase 1 / Phase 2 | 50 | Shanghai Chest HospitalOTHER | 1 | Jun 17, 2024 | clinicaltrials |
| NCT06462495 | Head-to-head Comparison of [18F]F-PSMA-N5 With [18F]F-PSMA-1007 PET/CT in PCa Diagnosis, Recurrence, and Metastasis | unknown | Early Phase 1 | 30 | Anhui Provincial HospitalOTHER_GOV | 1 | Jun 17, 2024 | clinicaltrials |
| NCT06462508 | Head-to-head Comparison of [18F]F-PSMA-N5 With [68Ga]Ga-PSMA-11 PET/CT in PCa Diagnosis, Recurrence, and Metastasis | unknown | Early Phase 1 | 30 | Anhui Provincial HospitalOTHER_GOV | 1 | Jun 17, 2024 | clinicaltrials |
| NCT06463171 | Phase II Trial of Almonertinib Plus Lastet for EGFR+ Non-small Cell Lung Cancer | unknown | Phase 2 | 60 | Shanghai Pulmonary Hospital, Shanghai, ChinaOTHER | 1 | Jun 17, 2024 | clinicaltrials |
| NCT03867799 | iSCORE: Immunotherapy Sequencing in COlon and REctal Cancer | unknown | Phase 2 | 25 | Royal Marsden NHS Foundation TrustOTHER | 1 | Jun 14, 2024 | clinicaltrials |
| NCT05766748 | Study of Effect of Azeliragon in Patients Refractory to Prior Treatment of Metastatic Pancreatic Cancer | unknown | Phase 1 / Phase 2 | 30 | Cantex PharmaceuticalsINDUSTRY | 1 | Jun 14, 2024 | clinicaltrials |
| NCT05832892 | Surufatinib Combined With KN046 and AG Regimen Chemotherapy as First-Line Treatment for Unresectable Advanced Pancreatic Cancer | unknown | Phase 1 / Phase 2 | 41 | Shanghai Zhongshan HospitalOTHER | 1 | Jun 14, 2024 | clinicaltrials |
| NCT06233292 | A Study of ZG005 in Patients With Advanced Solid Tumors | unknown | Phase 1 / Phase 2 | 484 | Suzhou Zelgen Biopharmaceuticals Co.,LtdINDUSTRY | 1 | Jun 14, 2024 | clinicaltrials |
| NCT06239298 | A Study of ZG005 Combined With Donafenib in Patients With Advanced Solid Tumor | unknown | Phase 1 / Phase 2 | 130 | Suzhou Zelgen Biopharmaceuticals Co.,LtdINDUSTRY | 1 | Jun 14, 2024 | clinicaltrials |
| NCT06372626 | Study of ZG005 in Combination With Etoposide and Cisplatin in Participants With Advanced Neuroendocrine Carcinoma. | unknown | Phase 1 / Phase 2 | 93 | Suzhou Zelgen Biopharmaceuticals Co.,LtdINDUSTRY | 1 | Jun 14, 2024 | clinicaltrials |
| NCT06458725 | Assessment of DW-MRI Measures : Reproducibility and Repeatability in Pelvic Imaging on MR-Linac With Healthy Volunteers(PILLAR) | unknown | N/A | 30 | Jules Bordet InstituteOTHER | 0 | Jun 14, 2024 | clinicaltrials |
| NCT06460766 | Validity and Reliability of the Inflammatory Arthritis Facilitators and Barriers to Physical Activity Questionnaire | unknown | — | 70 | Istanbul University - CerrahpasaOTHER | 1 | Jun 14, 2024 | clinicaltrials |
| NCT06460974 | The Effect of Stress Ball Application on Stress, Anxiety and Comfort During Chemotherapy in Women With Breast Cancer | unknown | N/A | 74 | Mersin UniversityOTHER | 1 | Jun 14, 2024 | clinicaltrials |
| NCT02042807 | To Evaluate the Effect of MCS® in Prostate Cancer Prevention(MCS-8) | unknown | Phase 2 | 702 | Health Ever Bio-Tech Co., Ltd.INDUSTRY | 1 | Jun 13, 2024 | clinicaltrials |
| NCT04818333 | A Study of SHR-A1811 in Subjects With Advanced Non-small Cell Lung Cancer | unknown | Phase 1 / Phase 2 | 157 | Jiangsu HengRui Medicine Co., Ltd.INDUSTRY | 1 | Jun 13, 2024 | clinicaltrials |
| NCT05717738 | Combined TACE, TKI/Anti-VEGF and ICIs as Conversion Therapy for Advanced Hepatocellular Carcinoma(CCGLC-008) | unknown | — | 300 | Tongji HospitalOTHER | 1 | Jun 13, 2024 | clinicaltrials |
| NCT06094777 | A Study of HY-0102 in Patients With Advanced Solid Tumors | unknown | Phase 1 | 50 | Shanghai YingLi Pharmaceutical Co. Ltd.INDUSTRY | 1 | Jun 13, 2024 | clinicaltrials |
| NCT06456203 | Trial of Artificial Intelligence for Chest Radiography(ACER) | unknown | N/A | 10,000 | Duke-NUS Graduate Medical SchoolOTHER | 0 | Jun 13, 2024 | clinicaltrials |
| NCT06456229 | Time to Return of Bowel Function Following Perioperative Probiotics in Colorectal Cancer Surgery(PICCS-1) | unknown | N/A | 162 | National University Hospital, SingaporeOTHER | 1 | Jun 13, 2024 | clinicaltrials |
| NCT06457282 | Studying The Association Between Environmental Exposure to PFAS and Breast Cancer in Assiut Governorate- Egypt | unknown | — | 42 | Assiut UniversityOTHER | 0 | Jun 13, 2024 | clinicaltrials |
| NCT06457464 | Clinical Outcomes and Prognostic Factors in Multiple Myeloma Patients | unknown | — | 100 | Assiut UniversityOTHER | 0 | Jun 13, 2024 | clinicaltrials |
| NCT04567446 | Discovery of Microbiome-based Biomarkers for Patients With Cancer Using Metagenomic Approach(ONCOBIOTICS) | unknown | — | 1,100 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Jun 12, 2024 | clinicaltrials |
| NCT05078671 | Pharmacokinetic Boosting of Olaparib to Improve Exposure, Tolerance and Cost-effectiveness(PROACTIVE) | unknown | Phase 4 | 160 | Radboud University Medical CenterOTHER | 1 | Jun 12, 2024 | clinicaltrials |
| NCT06454097 | Study on Radiogenomics Features Associated With Radiochemotherapy Sensitivity in Gliomas | unknown | N/A | 200 | Beijing Tiantan HospitalOTHER | 1 | Jun 12, 2024 | clinicaltrials |
| NCT06455072 | Nituzumab Plus Serplulimab Combined With SBRT in Cervical Cancer | unknown | Phase 2 | 37 | Fujian Cancer HospitalOTHER_GOV | 1 | Jun 12, 2024 | clinicaltrials |
| NCT06455722 | [68Ga]Ga-P15-041 PET/CT in Variety of Bone Tumors | unknown | Early Phase 1 | 30 | First Affiliated Hospital of Fujian Medical UniversityOTHER | 1 | Jun 12, 2024 | clinicaltrials |
| NCT06455735 | 68Ga-JH04 PET/CT in Patients With Various Types of Cancer | unknown | Early Phase 1 | 30 | First Affiliated Hospital of Fujian Medical UniversityOTHER | 1 | Jun 12, 2024 | clinicaltrials |
| NCT06455761 | 68Ga-DOTA-NI-FAPI04 PET/CT in Patients With Various Types of Cancer | unknown | Early Phase 1 | 30 | First Affiliated Hospital of Fujian Medical UniversityOTHER | 1 | Jun 12, 2024 | clinicaltrials |
| NCT05110131 | Evaluation of the Synergistic Impact of Needle and Forceps Biopsy With Electromagnetic Navigation Bronchoscopy | unknown | N/A | 142 | Seoul National University Bundang HospitalOTHER | 1 | Jun 11, 2024 | clinicaltrials |
| NCT05516810 | The Accuracy of Ultrasound Diagnosis of Hydatidiform Moles | unknown | — | 500 | King's College Hospital NHS TrustOTHER | 1 | Jun 11, 2024 | clinicaltrials |
| NCT05607602 | Are Uterine Fibroids Pro-thrombotic? | unknown | — | 105 | King's College Hospital NHS TrustOTHER | 1 | Jun 11, 2024 | clinicaltrials |
| NCT06293066 | Performance of Ultrasound in Women With Postmenopausal or Abnormal Uterine Bleeding Between White and Black Ethnic Groups- a Retrospective Cohort Study. | unknown | — | 330 | King's College Hospital NHS TrustOTHER | 1 | Jun 11, 2024 | clinicaltrials |
| NCT06451536 | Ga-68 FAPI PET Before Immunotherapy(FAPBI) | unknown | N/A | 30 | Ankara UniversityOTHER | 1 | Jun 11, 2024 | clinicaltrials |
| NCT06417294 | Effects of a 3D-Printed Port-A Catheter Model Training Course | unknown | N/A | 120 | Fu Jen Catholic UniversityOTHER | 1 | Jun 10, 2024 | clinicaltrials |
| NCT06429189 | Home-Combo: an Online Home-based Combined Exercise Intervention for Women With Breast Cancer | unknown | N/A | 98 | Grupo LusófonaOTHER | 1 | Jun 10, 2024 | clinicaltrials |
| NCT06448455 | Observation on the Frailty Status of Lung Cancer Patients | unknown | — | 200 | Peking University Third HospitalOTHER | 1 | Jun 10, 2024 | clinicaltrials |
| NCT06450080 | Study of the Relationship Between Clinical, Imaging and Biological Data in Patients With Squamous Cell Carcinoma of the Tongue(ClimaBio) | unknown | N/A | 60 | Centre Hospitalier Universitaire, AmiensOTHER | 1 | Jun 10, 2024 | clinicaltrials |
| NCT06450145 | Evaluate the Efficacy and Safety of Interferon-α Combined With ATO in the Treatment of Arsenic-resistant APL(APL) | unknown | N/A | 15 | Zhejiang Provincial People's HospitalOTHER | 1 | Jun 10, 2024 | clinicaltrials |
| NCT02910895 | A Platform of Patient Derived Xenografts (PDX) and 2D/3D Cell Cultures of Soft Tissue Sarcomas (STS)(SarcomaPDX) | unknown | N/A | 40 | The Netherlands Cancer InstituteOTHER | 1 | Jun 7, 2024 | clinicaltrials |
Data updated 23 days agoSource updated Jun 20, 2024source: clinicaltrials